ACTRN12616001007426暂停未知
Evaluating the Impact of Androgen Deprivation Therapy on Cognition in an Australian Sample of Prostate Cancer Patients
epean and Blue Mountains Local Health District0 个研究点目标入组 90 人开始时间: 2016年7月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 暂停
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Male
入选标准
- •*Gender eligible for study: male
- •*Prostate cancer diagnosis
- •*MMSE > 24
- •*ECOG status between 0 – 1
- •*Speak and read English
- •* Planned to commence ADT within 1 month
- •* No prior or current ADT
排除标准
- •Participants are not eligible to participate on the following basis:
- •*Commenced on ADT
- •*Prior ADT
- •*Previous or current chemotherapy treatment
- •*Previous or current severe psychiatric history as defined by
- •- A diagnosed mental illness involving psychosis
- •- Hospitalisation for mental health difficulties
- •*Current diagnosis of major depressive episode or an anxiety disorder
- •*Previous or current neurological difficulties e.g. Seizures or stroke
- •*Previous or current significant heart disease e.g. Myocardial infarction, Congestive Cardiac Failure
- •*History of brain cancer
- •*Patients with a past history of cancer in the 5 years before registration except for the following: Patients with squamous or basal cell carcinoma of the skin that has been effectively treated.
- •*Life expectancy less than 1 year
- •*Prior orchidectomy
- •*Participation in other projects involving cognitive testing.
研究者
相似试验
进行中（未招募）
1 期
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigeMedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10071119 Term: Hormone-dependent prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Metastatic prostate cancerEUCTR2018-004853-26-FITurku University Hospital35
进行中（未招募）
1 期
The effect of androgen deprivation therapy on prostate specific membrane antigen (PSMA)Prostate cancerEUCTR2017-002345-29-FITurku University Hospital5
招募中
不适用
To determine whether androgen deprivation therapy or androgen blockage therapy upregulates receptor activity of Gallium68 Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) scans for men with castrate resistant prostate cancer.Metastatic Prostate CancerACTRN12617001116314St Vincent's Hospital, Sydney20
进行中（未招募）
不适用
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)Prostate CancerNCT03703778Chinese University of Hong Kong300
招募中
不适用
Effect of androgen deprivation therapy on uptake of PSMA ligand in patients with salivary duct carcinoma: an explorative study.NL-OMON48488Radboud Universitair Medisch Centrum14